Sanjay Mathew, MD
Enriched profileDepartment Head and Professor, Psychiatry and Behavioral Sciences, Texas A&M University Naresh K. Vashisht College of Medicine (effective Sept. 1, 2025) · Texas A&M University Naresh K. Vashisht College of Medicine
Sanjay Mathew is Department Head and Professor, Psychiatry and Behavioral Sciences, Texas A&M University Naresh K. Vashisht College of Medicine (effective Sept. 1, 2025) at Texas A&M University Naresh K. Vashisht College of Medicine. OpenAlex indexes 282 publications with 16,664 citations (h-index 63); ClinicalTrials.gov lists 5 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Psychiatry profiles in the findmyKOL directory. Clarivate lists Sanjay Mathew as a Highly Cited Researcher (Cross-Field, 2021, 2024-2025).
Data verified 7 Sept 2026
Overview
Updated 16 Oct 2026
Sanjay Mathew, MD, is Department Head and Professor, Psychiatry and Behavioral Sciences, Texas A&M University Naresh K. Vashisht College of Medicine (effective Sept. 1, 2025). The public record shows 282 publications with 16,664 citations (h-index 63), centered on Depression (MDD). It also documents an investigator role on 5 registered clinical trials, industry payments reported by 12 companies, 6 NIH-funded awards (2010–2026).
- Most recent indexed publication: 2026 · Nature communications
- Top research focus: Depression (MDD)
- 5 registered trials on ClinicalTrials.gov
- Open Payments reporting from 12 companies
Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 23 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 16 Oct 2026
Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:
- Deep Brain Stimulation of Treatment-Resistant Bipolar Depression
Sponsor: Wayne Goodman MD
- Ketamine for Treatment Resistant Late-Life Depression
Sponsor: VA Office of Research and Development
- Optimization of IV Ketamine for Treatment Resistant Depression
Sponsor: Baylor College of Medicine
Industry payments
Updated 16 Oct 2026
12 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20255 payments
- Neos Therapeutics, LPProgram year20251 payment
- LivaNova USA, Inc.Program year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%SSRI28.8%Escitalopram Oxalate100%Part D<11 patientsBenzodiazepine28.8%Alprazolam100%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 16 Oct 2026
6 NIH research awards on record, funded 2010–2026 per NIH RePORTER. The latest:
- A brief automated neurocognitive training to enhance the real-world impact of ketamine's rapid antidepressant effect
Texas A&m University Health Science Ctr
FY2026$962,074R01MH136178 - Gamma oscillations as a prognostic marker for ketamine therapy in treatment resistant depression
Texas A&m University Health Science Ctr
FY2025$156,133R21MH133198 - Gamma oscillations as a prognostic marker for ketamine therapy in treatment resistant depression
Baylor College of Medicine
FY2025$77,784R21MH133198
Publications
Updated 16 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Author Correction: Intracranial directed connectivity links subregions of the prefrontal cortex to major depression.
Nature communications
Erratum2026 - Effects of KCNQ potassium channel modulation on ventral tegmental area activity and connectivity in individuals with depression and anhedonia.
Molecular psychiatry
Clinical Trial2025 - Intracranial directed connectivity links subregions of the prefrontal cortex to major depression.
Nature communications
Article2025 - Author Correction: Beta activity in human anterior cingulate cortex mediates reward biases.
Nature communications
Erratum2025
Online presence
Updated 16 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/sanjay-mathew-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - Other
bcm.edu/people-search/sanjay-mathew-26251
- ResearchGate
researchgate.net/profile/Sanjay-Mathew-2
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Facebook
facebook.com/uth.psychiatry/posts/sanjay-mathew-md-will-be-speaking-on-ketamineesketamine-for-treatment-resistant-/1373120301482551
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - Other
consultant360.com/podcast/consultant360/sanjay-j-matthew-md-ketamines-mechanism-action
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →consultant360.com ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗ - LinkedIn
LinkedIn profile listing current title as Texas A&M University Naresh K. Vashisht College of Medicine (page itself auth-walled; corroborated via search-result title/snippet)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 16 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.tamu.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.tamu.edu ↗
- Board Certified
American Board of Psychiatry and Neurology - Psychiatry (Diplomate #N5849)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.tamu.edu ↗
Editorial & leadership roles
journal and society appointments- President
Board of Directors, Anxiety and Depression Association of America (ADAA), effective Jan. 1, 2026 (previously President-Elect and Chief Medical Officer)
2026verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vitalrecord.tamu.edu ↗ - Fellow
American College of Neuropsychopharmacology (ACNP)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vitalrecord.tamu.edu ↗ - Board Member
American Society of Clinical Psychopharmacology (ASCP)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vitalrecord.tamu.edu ↗ - Member
Scientific Council, American Foundation for Suicide Prevention (AFSP)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vitalrecord.tamu.edu ↗ - Associate Editor
American Journal of Psychiatry
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →psychiatryonline.org ↗
Highly Cited Researcher
Clarivate's annual list, by award category and year- Cross-Field202120242025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clarivate.com ↗
Secondary affiliations
appointments beyond the home institution- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →clexio.com ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →consultant360.com ↗
- Featured expert
"What is MDD" YouTube video series produced with ADAA on depression/MDD symptoms and treatment
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Charles Nemeroff, MD
Dell Medical School
Maurizio Fava, MD
Massachusetts General Hospital
John Krystal, MD
Yale University
Jeffrey Lieberman, MD
Columbia University College of Physicians and Surgeons